Drug company Actelion to pay $360M in kickback probe

BOSTON (AP) — A pharmaceutical company has agreed to pay $360 million to resolve allegations that it used a charitable foundation to pay kickbacks to Medicare patients.

The U.S. attorney’s office in Boston announced the settlement Thursday with Actelion Pharmaceuticals US Inc., which was acquired last year by health care giant Johnson & Johnson.

Federal prosecutors say South San Francisco-based Actelion illegally used a purportedly independent charity to cover the co-payments of thousands of Medicare patients taking its pulmonary arterial high blood pressure drugs.

Prosecutors say that helped the company convince patients to buy its drugs when the prices it set would have otherwise prevented them from doing so.

Actelion spokeswoman Caroline Pavis says in a statement that the company is committed to complying with all laws and regulations.

Top Stories

STORM TEAM 4 FORECAST
Sioux City
21°
Yankton
23°
Spencer
23°
Norfolk
27°
Storm Lake
21°
Denison
23°
A nice recovery for Monday afternoon

A nice recovery for Monday afternoon

By mid-morning that fog clears away and we will be left with sunny skies and temperatures near 30 degrees.

Click for forecast details...
Connect With KTIV
Top Stories

New phishing e-mails hitting consumers this season

The e-mails appear to come from major retailers, Amazon and Apple, aimed at confirming purchases that were never made.

KTIV transmitter site maintenance work set for Monday

Full power is expected to return at 5 p.m. Monday.

Ernst says she’ll seek re-election to US Senate in 2020

The 48-year-old military veteran was elected to the U.S. Senate in 2014 after serving four years in the Iowa Senate.

Nebraska health officials: 2 flu deaths reported this season

The two 65-year-olds died from areas covered by the Lincoln-Lancaster County Health Department and the North Central District Health Department

Cohen filings spark talks of Trump impeachment

Michael Cohen filings renew discussion of Trump's impeachment.

Scroll to top
Skip to content